Teva Pharmaceutical Industries Limited (TEVA) stock analysis

In our weekly check, Teva Pharmaceutical Industries Limited is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 14 pass, warnings: 6, red flags: 3.

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Israel, listed on NYSE as TEVA.

What our checks show for TEVA

Red flags

Warning signs

Strengths

Next earnings report: 2027-01-27

Similar companies

HLN · TAK · ZTS · VTRS · ELAN · ALKS

Questions

What grade does Teva Pharmaceutical Industries Limited (TEVA) have?

In our weekly check, Teva Pharmaceutical Industries Limited is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 14 pass, warnings: 6, red flags: 3. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of TEVA stock?

This week's biggest flags for Teva Pharmaceutical Industries Limited: High debt, Thin margins, Deep past fall. In total 9 of 23 checks show a warning or a red flag.

What does Teva Pharmaceutical Industries Limited do?

Teva Pharmaceutical Industries Limited is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Israel, listed on NYSE as TEVA.

When does Teva Pharmaceutical Industries Limited report earnings next?

The next earnings report is expected on 2027-01-27. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis